Product
Td-Impfstoff Merieux
1 clinical trial
2 indications
Indication
DiphtheriaIndication
TetanusClinical trial
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Booster Immunization With Bivalent Vaccine Against Tetanus and Diphtheria CLODIVAC (IBSS Biomed S.A.) and Td-Impfstoff Mérieux (Sanofi Pasteur) in Healthy Adults.Status: Active (not recruiting), Estimated PCD: 2024-03-04